PTSM: Pharmaceutical Technology Sourcing and Management, Jan 9, 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
PTSM: Pharmaceutical Technology Sourcing and Management, Jan 9, 2013
Global Feature
2013: The Year Ahead
By Patricia Van Arnum
As a new year begins, what may be on the horizon for 2013 for the biopharmaceutical/pharmaceutical companies and their suppliers? A look ahead into what issues are shaping the industry.
Biologics
Venture-Capital Stays Strong in Biotech Financing
By Patricia Van Arnum
Financing from initial public offerings and global mergers and acquisitions were down in 2012 and venture-capital funding stayed strong.
Outsourcing
Acquisitions Reshape the Bio/Pharm Services Industry
By Jim Miller
The quest to build critical mass and broaden capabilities has been a key factor in dealmaking.
CSR and Sustainability Forum
GlaxoSmithKline Uses Mobile Technology to Advance Vaccinations in the Developing World
By Patricia Van Arnum
GlaxoSmithKline partners with the mobile telecommunications company Vodafone to tackle common infectious diseases in Africa.
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
14%
To select process for new products only
23%
To select processes for both new and legacy products
20%
Do not use QbD
25%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here